Well, if nothing else it is a lesson learned about investing in clinical biotech. The fact is it usually takes years for the payoff. And luck plays a part. The bad luck here is that a shady short cartel latched onto this one, which makes it more painful to wait, psychologically. Which is what their plan is designed to accomplish.